ISEM, CNRS, IRD, EPHE, University of Montpellier, Montpellier, France.
ICREA-Complex Systems Lab, Universitat Pompeu Fabra, Barcelona, Spain.
Bioessays. 2023 May;45(5):e2200215. doi: 10.1002/bies.202200215. Epub 2023 Mar 2.
Human cancers comprise an heterogeneous array of diseases with different progression patterns and responses to therapy. However, they all develop within a host context that constrains their natural history. Since it occurs across the diversity of organisms, one can conjecture that there is order in the cancer multiverse. Is there a way to capture the broad range of tumor types within a space of the possible? Here we define the oncospace, a coordinate system that integrates the ecological, evolutionary and developmental components of cancer complexity. The spatial position of a tumor results from its departure from the healthy tissue along these three axes, and progression trajectories inform about the components driving malignancy across cancer subtypes. We postulate that the oncospace topology encodes new information regarding tumorigenic pathways, subtype prognosis, and therapeutic opportunities: treatment design could benefit from considering how to nudge tumors toward empty evolutionary dead ends in the oncospace.
人类癌症包括具有不同进展模式和对治疗反应的异质性疾病。然而,它们都在宿主环境中发展,这种环境限制了它们的自然史。由于它发生在生物体的多样性中,人们可以推测癌症的多元宇宙中有秩序。有没有一种方法可以在可能的范围内捕捉广泛的肿瘤类型?在这里,我们定义了肿瘤空间,这是一个坐标系统,它整合了癌症复杂性的生态、进化和发育成分。肿瘤的空间位置是由其沿着这三个轴偏离健康组织的程度决定的,而进展轨迹则可以提供有关驱动癌症亚型恶性程度的成分的信息。我们假设肿瘤空间拓扑结构编码了关于肿瘤发生途径、亚型预后和治疗机会的新信息:治疗设计可以从考虑如何将肿瘤推向肿瘤空间中的进化死胡同中获益。